Fmoc-L-Asn(GlcNAc4)-OH

Fmoc-L-Asn(GlcNAc4)-OH is an Fmoc-protected L-asparagine derivative bearing a side-chain N-acetylglucosamine functionality at the 4-position, providing a chiral amino acid building block with an anomeric sugar substituent and multiple oxygenated groups. The molecule contains an Fmoc carbamate on the alpha-amino function, a free carboxylic acid for peptide coupling, and a glycosylated amide side chain that can participate in hydrogen bonding and selective derivatization. The GlcNAc4 moiety introduces acetamide and hydroxyl groups that can be protected or selectively activated depending on the glycosylation chemistry and subsequent deprotection strategy. The compound's protected amino acid framework and carbohydrate-bearing side chain make it suitable as a peptide synthesis intermediate for constructing glycopeptide-like motifs and for generating downstream glycosylated analogs in applied amino acid chemistry.

1. Glycopeptide Synthesis

Fmoc-L-Asn(GlcNAc4)-OH supports glycopeptide and glycosylated peptide assembly in solid-phase peptide synthesis by combining an Fmoc-protected alpha-amino group with a carboxylic acid handle for coupling. The L-asparagine backbone provides the canonical amide side-chain geometry, while the GlcNAc4 substituent offers a carbohydrate-functional motif that can be carried through peptide elongation steps with controlled deprotection. The Fmoc strategy enables orthogonal removal of the N-protecting group under base conditions, allowing sequential peptide coupling without directly perturbing the sugar-bearing side chain. The resulting glycosylated peptide products and peptide fragments can be used to generate glycan-presenting scaffolds for biochemical research and synthetic methodology development.

2. Chemical Biology Probes

Fmoc-L-Asn(GlcNAc4)-OH serves as a defined amino acid derivative for chemical biology workflows that require site-specific presentation of N-acetylglucosamine-like features on peptide scaffolds. The sugar's acetamide and hydroxyl groups enable strong hydrogen-bonding interactions and can be leveraged for receptor-binding studies, lectin interaction mapping, and glycan-mimetic design without relying on heterogeneous glycosylation mixtures. The asparagine-linked architecture provides a structurally consistent attachment point for conjugation into larger biomolecular constructs, including peptide tags and scaffolded probes. Downstream transformations can convert the carbohydrate functionality into labeled or affinity-reactive analogs suitable for interrogating glycan recognition pathways and for building molecular tools in applied biochemical research.

3. Protected Amino Acid Chemistry

Fmoc-L-Asn(GlcNAc4)-OH functions as a chiral, protected amino acid intermediate in protected amino acid synthesis where orthogonality between the Fmoc group and carbohydrate functional groups is required. The Fmoc carbamate protects the alpha-amine for standard peptide coupling cycles, while the sugar-bearing side chain can be managed through selective protection, activation, or stability-minded handling during synthesis planning. The free carboxylic acid enables conversion to activated esters or coupling-ready derivatives under process-compatible conditions, supporting scalable intermediate preparation. The defined stereochemistry at the alpha-carbon and the fixed orientation of the asparagine side chain support reproducible incorporation into peptide building blocks and enable controlled downstream deprotection to expose functional sites for further derivatization.

4. Bioconjugation Linkers

Fmoc-L-Asn(GlcNAc4)-OH can be applied to bioconjugation chemistry by providing a glycosylated amino acid unit that integrates into peptide-based linkers and biomolecule modification reagents. The carbohydrate functionality introduces multiple hydroxyl groups and an N-acetylamide, which can be used to tune hydrophilicity, spacing, and recognition properties in conjugates assembled with peptide coupling or fragment assembly strategies. The Fmoc-protected amino acid format supports stepwise construction of conjugation-ready peptides, after which Fmoc removal and subsequent functionalization can yield reactive handles for coupling to proteins, polymers, or surfaces. The resulting glycan-presenting conjugates can serve as defined reagents for analytical research, binding assays, and materials-oriented biomolecular patterning.

5. Peptidomimetic And SAR Studies

Fmoc-L-Asn(GlcNAc4)-OH enables peptidomimetic construction and structure-activity relationship studies by allowing incorporation of a glycosylated asparagine motif into defined peptide analog libraries. The asparagine amide side chain and the GlcNAc4 substituent together create a recognizable hydrogen-bonding and polarity pattern that can be systematically varied through peptide sequence changes while keeping the sugar-bearing stereochemical framework constant. The Fmoc-protected amino acid format supports parallel synthesis of analogs with controlled N-terminal protection state and consistent coupling chemistry across library members. Downstream, these analogs can be used to generate comparative datasets for molecular design and SAR investigations focused on glycan-dependent recognition features in biochemical systems.

6. Pharmaceutical Intermediate Preparation

Fmoc-L-Asn(GlcNAc4)-OH is suitable for pharmaceutical intermediate preparation where carbohydrate-bearing peptide fragments are required as defined inputs for process chemistry and fine chemical synthesis. The presence of an Fmoc-protected amine and a free carboxylic acid supports manufacturing-minded route design that separates peptide assembly steps from later functional-group exposure or conversion. The stable, chiral amino acid scaffold can be carried through controlled protection/deprotection sequences to produce glycosylated intermediates used in the synthesis of investigational peptide-like molecules and analytical reference materials. The compound's functional-group pattern aligns with industrially relevant intermediate generation for downstream derivatization, including conversion into coupling-ready forms and controlled transformation of carbohydrate functionality during synthetic elaboration.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines